# reload+after+2024-01-23 13:39:54.289929
address1§60 Gracechurch Street
address2§6th Floor
city§London
zip§EC3V 0HR
country§United Kingdom
phone§44 1332 690061
website§https://www.n4pharma.com
industry§Drug Manufacturers—Specialty & Generic
sector§Healthcare
longBusinessSummary§N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
fullTimeEmployees§5
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Nigel James Theobald', 'age': 59, 'title': 'Founder, CEO & Executive Director', 'yearBorn': 1964, 'fiscalYear': 2022, 'totalPay': 77500, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. David  Templeton', 'title': 'Executive Director & Technical Director', 'fiscalYear': 2022, 'totalPay': 46500, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Luke Sebastian Cairns', 'age': 45, 'title': 'Executive Director', 'yearBorn': 1978, 'fiscalYear': 2022, 'totalPay': 41333, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Rob  Harris', 'title': 'Head of CMC Development', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Andrew  Leishman', 'title': 'Consultant', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
exDividendDate§864000000
payoutRatio§0.0
beta§0.047
currency§GBp
exchange§LSE
quoteType§EQUITY
shortName§N4 PHARMA PLC ORD 0.4P
longName§N4 Pharma Plc
firstTradeDateEpochUtc§583743600
timeZoneFullName§Europe/London
timeZoneShortName§GMT
uuid§3e42e642-4b82-3e3d-aeba-5f0b80d0a82e
recommendationKey§none
quickRatio§27.878
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
